Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 250

1.

Effect of late prophylaxis in hemophilia on joint status: a randomized trial.

Manco-Johnson MJ, Lundin B, Funk S, Peterfy C, Raunig D, Werk M, Kempton CL, Reding MT, Goranov S, Gercheva L, Rusen L, Uscatescu V, Pierdominici M, Engelen S, Pocoski J, Walker D, Hong W.

J Thromb Haemost. 2017 Aug 24. doi: 10.1111/jth.13811. [Epub ahead of print]

PMID:
28836341
2.

Intracellular Action of a Secreted Peptide Required for Fungal Virulence.

Homer CM, Summers DK, Goranov AI, Clarke SC, Wiesner DL, Diedrich JK, Moresco JJ, Toffaletti D, Upadhya R, Caradonna I, Petnic S, Pessino V, Cuomo CA, Lodge JK, Perfect J, Yates JR 3rd, Nielsen K, Craik CS, Madhani HD.

Cell Host Microbe. 2016 Jun 8;19(6):849-64. doi: 10.1016/j.chom.2016.05.001. Epub 2016 May 19.

3.

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis.

Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P, Deodhar A, Porter B, Martin R, Andersson M, Mpofu S, Richards HB; MEASURE 1 Study Group; MEASURE 2 Study Group.

N Engl J Med. 2015 Dec 24;373(26):2534-48. doi: 10.1056/NEJMoa1505066.

4.

Efficacy, safety and pharmacokinetic profiles of a plasma-derived VWF/FVIII concentrate (VONCENTO®) in subjects with haemophilia A (SWIFT-HA study).

Skotnicki A, Lissitchkov TJ, Mamonov V, Buevich E, Kuliczkowski K, Goranov S, Kłoczko J, Klukowska A, Stankovic S, Gercheva L, Chernova T, Hellmann A, Dmoszyńska A, Zawilska K, Veldman A, Joch C, Seifert W.

Thromb Res. 2016 Jan;137:119-25. doi: 10.1016/j.thromres.2015.10.014. Epub 2015 Oct 13.

PMID:
26614676
5.

Multilayered Magnetic Gelatin Membrane Scaffolds.

Samal SK, Goranov V, Dash M, Russo A, Shelyakova T, Graziosi P, Lungaro L, Riminucci A, Uhlarz M, Bañobre-López M, Rivas J, Herrmannsdörfer T, Rajadas J, De Smedt S, Braeckmans K, Kaplan DL, Dediu VA.

ACS Appl Mater Interfaces. 2015 Oct 21;7(41):23098-109. doi: 10.1021/acsami.5b06813. Epub 2015 Oct 9.

6.

Long-term use of ticagrelor in patients with prior myocardial infarction.

Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Oude Ophuis T, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS; PEGASUS-TIMI 54 Steering Committee and Investigators.

N Engl J Med. 2015 May 7;372(19):1791-800. doi: 10.1056/NEJMoa1500857. Epub 2015 Mar 14.

7.

Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma.

Stewart AK, Rajkumar SV, Dimopoulos MA, Masszi T, Špička I, Oriol A, Hájek R, Rosiñol L, Siegel DS, Mihaylov GG, Goranova-Marinova V, Rajnics P, Suvorov A, Niesvizky R, Jakubowiak AJ, San-Miguel JF, Ludwig H, Wang M, Maisnar V, Minarik J, Bensinger WI, Mateos MV, Ben-Yehuda D, Kukreti V, Zojwalla N, Tonda ME, Yang X, Xing B, Moreau P, Palumbo A; ASPIRE Investigators.

N Engl J Med. 2015 Jan 8;372(2):142-52. doi: 10.1056/NEJMoa1411321. Epub 2014 Dec 6.

8.

Functional profiling of human fungal pathogen genomes.

Goranov AI, Madhani HD.

Cold Spring Harb Perspect Med. 2014 Nov 6;5(3):a019596. doi: 10.1101/cshperspect.a019596. Review.

9.

Health Care Resource Utilization (HCRU) In Hospitalized Febrile Neutropenia (FN) Patients Treated With Chemotherapy For Solid Tumors (ST) And Hematological Malignancies (HM) In Bulgaria.

Gercheva L, Goranov S, Raynov J, Mihaylova Z, Mihaylov G, Karanikolov S, Petrova R.

Value Health. 2014 Nov;17(7):A656. doi: 10.1016/j.jval.2014.08.2397. Epub 2014 Oct 26. No abstract available.

10.

Tofacitinib versus methotrexate in rheumatoid arthritis.

Lee EB, Fleischmann R, Hall S, Wilkinson B, Bradley JD, Gruben D, Koncz T, Krishnaswami S, Wallenstein GV, Zang C, Zwillich SH, van Vollenhoven RF; ORAL Start Investigators.

N Engl J Med. 2014 Jun 19;370(25):2377-86. doi: 10.1056/NEJMoa1310476.

11.

Smart magnetic poly(N-isopropylacrylamide) to control the release of bio-active molecules.

Dionigi C, Lungaro L, Goranov V, Riminucci A, Piñeiro-Redondo Y, Bañobre-López M, Rivas J, Dediu V.

J Mater Sci Mater Med. 2014 Oct;25(10):2365-71. doi: 10.1007/s10856-014-5159-7. Epub 2014 Jan 30.

PMID:
24477874
12.

In silico prediction of the cell proliferation in porous scaffold using model of effective pore.

Makhaniok A, Haranava Y, Goranov V, Panseri S, Semerikhina S, Russo A, Marcacci M, Dediu V.

Biosystems. 2013 Dec;114(3):227-37. doi: 10.1016/j.biosystems.2013.10.001. Epub 2013 Oct 17.

PMID:
24141144
13.

Changes in cell morphology are coordinated with cell growth through the TORC1 pathway.

Goranov AI, Gulati A, Dephoure N, Takahara T, Maeda T, Gygi SP, Manalis S, Amon A.

Curr Biol. 2013 Jul 22;23(14):1269-79. doi: 10.1016/j.cub.2013.05.035. Epub 2013 Jun 27.

14.

Academic opportunities within clinical oncology training.

Goranov BB, Drew Y, Graham J, Iqbal MS, Kagzi M, Mahtab N, Pearson R, Smith E, Mulvenna P.

Clin Oncol (R Coll Radiol). 2013 Jul;25(7):446. doi: 10.1016/j.clon.2013.03.004. Epub 2013 Apr 11. No abstract available.

PMID:
23582955
15.

Randomized, controlled, parallel-group trial of routine prophylaxis vs. on-demand treatment with sucrose-formulated recombinant factor VIII in adults with severe hemophilia A (SPINART).

Manco-Johnson MJ, Kempton CL, Reding MT, Lissitchkov T, Goranov S, Gercheva L, Rusen L, Ghinea M, Uscatescu V, Rescia V, Hong W.

J Thromb Haemost. 2013 Jun;11(6):1119-27. doi: 10.1111/jth.12202. Erratum in: J Thromb Haemost. 2014 Jan;12(1):119-22.

16.

A randomized, double-blind, placebo-controlled trial of a chemokine receptor 2 (CCR2) antagonist in posttraumatic neuralgia.

Kalliomäki J, Attal N, Jonzon B, Bach FW, Huizar K, Ratcliffe S, Eriksson B, Janecki M, Danilov A, Bouhassira D; AZD2423 PTN Study Group.

Pain. 2013 May;154(5):761-7. doi: 10.1016/j.pain.2013.02.003. Epub 2013 Feb 13.

PMID:
23523116
17.

Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study.

van der Heijde D, Tanaka Y, Fleischmann R, Keystone E, Kremer J, Zerbini C, Cardiel MH, Cohen S, Nash P, Song YW, Tegzová D, Wyman BT, Gruben D, Benda B, Wallenstein G, Krishnaswami S, Zwillich SH, Bradley JD, Connell CA; ORAL Scan Investigators.

Arthritis Rheum. 2013 Mar;65(3):559-70. doi: 10.1002/art.37816.

18.

Tofacitinib or adalimumab versus placebo in rheumatoid arthritis.

van Vollenhoven RF, Fleischmann R, Cohen S, Lee EB, García Meijide JA, Wagner S, Forejtova S, Zwillich SH, Gruben D, Koncz T, Wallenstein GV, Krishnaswami S, Bradley JD, Wilkinson B; ORAL Standard Investigators.

N Engl J Med. 2012 Aug 9;367(6):508-19. doi: 10.1056/NEJMoa1112072. Erratum in: N Engl J Med. 2013 Jul 18;369(3):293.

19.

Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis.

Fleischmann R, Kremer J, Cush J, Schulze-Koops H, Connell CA, Bradley JD, Gruben D, Wallenstein GV, Zwillich SH, Kanik KS; ORAL Solo Investigators.

N Engl J Med. 2012 Aug 9;367(6):495-507. doi: 10.1056/NEJMoa1109071.

20.

Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial.

Knauf WU, Lissitchkov T, Aldaoud A, Liberati AM, Loscertales J, Herbrecht R, Juliusson G, Postner G, Gercheva L, Goranov S, Becker M, Fricke HJ, Huguet F, Del Giudice I, Klein P, Merkle K, Montillo M.

Br J Haematol. 2012 Oct;159(1):67-77. doi: 10.1111/bjh.12000. Epub 2012 Aug 4.

PMID:
22861163

Supplemental Content

Loading ...
Support Center